The effectiveness and value of betibeglogene autotemcel for the management of transfusion-dependent beta-thalassemia
- PMID: 36282936
- PMCID: PMC10372978
- DOI: 10.18553/jmcp.2022.28.11.1316
The effectiveness and value of betibeglogene autotemcel for the management of transfusion-dependent beta-thalassemia
References
-
- Origa R. beta-Thalassemia. Genet Med. 2017;19(6):609-19. - PubMed
-
- Cappellini MD, Cohen A, Porter JB, Taher AT, Viprakasit V, eds. Guidelines for the Management of Transfusion Dependent Thalassemia (TDT), 3rd edition. Thalassemia International Federation; 2014. - PubMed
-
- Cappellini MD, Cohen A, Porter JB, Taher AT, Viprakasit V, eds. 2021. Guidelines for the Management of Transfusion Dependent Thalassemia (TDT), 4th edition. Thalassemia International Federation; 2021. - PubMed
-
- Angelucci E, Benz EJJ, eds. Hematopoietic cell transplantation for transfusion-dependent thalassemia. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate, Inc; 2021. https://www.uptodate.com/contents/hematopoietic-cell-transplantation-for.... Accessed February 1, 2022.
MeSH terms
LinkOut - more resources
Full Text Sources
